Literature DB >> 33216464

Phloretin, an Apple Polyphenol, Inhibits Pathogen-Induced Mucin Overproduction.

Rahel L Birru1, Kiflai Bein1, Heather Wells1, Natalya Bondarchuk1, Aaron Barchowsky1, Yuanpu Peter Di1, George D Leikauf1.   

Abstract

SCOPE: Bacterial infection induces mucus overproduction, contributing to acute exacerbations and lung function decline in chronic respiratory diseases. A diet enriched in apples may provide protection from pulmonary disease development and progression. This study examined whether phloretin, an apple polyphenol, inhibits mucus synthesis and secretion induced by the predominant bacteria associated with chronic respiratory diseases. METHODS AND
RESULTS: The expression of mucus constituent mucin 5AC (MUC5AC) in FVB/NJ mice and NCI-H292 epithelial cells is analyzed. Nontypeable Haemophilus influenzae (NTHi)-infected mice developed increased MUC5AC mRNA, which a diet containing phloretin inhibited. In NCI-H292 cells, NTHi, Moraxella catarrhalis, Streptococcus pneumoniae, and Pseudomonas aeruginosa increased MUC5AC mRNA, which phloretin inhibited. Phloretin also diminished NTHi-induced MUC5AC protein secretion. NTHi-induced increased MUC5AC required toll-like receptor 4 (TLR4) and NADH oxidase 4 (NOX4) signaling and subsequent activation of the epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) pathway. Phloretin inhibited NTHi-induced TLR4/NOX4 and EGFR/MAPK signaling, thereby preventing increased MUC5AC mRNA. EGFR activation can also result from increased EGFR ligand synthesis and subsequent ligand activation by matrix metalloproteinases (MMPs). In NCI-H292 cells, NTHi increased EGFR ligand and MMP1 and MMP13 mRNA, which phloretin inhibited.
CONCLUSIONS: In summary, phloretin is a promising therapeutic candidate for preventing bacterial-induced mucus overproduction.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  epidermal growth factor; matrix metalloproteinase; mucin; reactive oxygen species; toll-like receptor 4

Mesh:

Substances:

Year:  2020        PMID: 33216464      PMCID: PMC8163070          DOI: 10.1002/mnfr.202000658

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  61 in total

1.  Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways.

Authors:  C A Hewson; J J Haas; N W Bartlett; S D Message; V Laza-Stanca; T Kebadze; G Caramori; J Zhu; M R Edbrooke; L A Stanciu; O M Kon; A Papi; P K Jeffery; M R Edwards; S L Johnston
Journal:  Eur Respir J       Date:  2010-06-04       Impact factor: 16.671

2.  Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation.

Authors:  K Venuprasad; Balamayooran Theivanthiran; Brandi Cantarel
Journal:  J Vis Exp       Date:  2016-03-02       Impact factor: 1.355

Review 3.  Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases.

Authors:  P-R Burgel; J A Nadel
Journal:  Eur Respir J       Date:  2008-10       Impact factor: 16.671

4.  The role of Nox4 in oxidative stress-induced MUC5AC overexpression in human airway epithelial cells.

Authors:  Hyun Jik Kim; Young-Duck Park; Uk Yeol Moon; Jun-Hee Kim; Ju Hyun Jeon; Jeung-Gweon Lee; Yun Soo Bae; Joo-Heon Yoon
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-06       Impact factor: 6.914

5.  Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells.

Authors:  Elisabetta Pace; Maria Ferraro; Liboria Siena; Mario Melis; Angela M Montalbano; Malcolm Johnson; Maria R Bonsignore; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2008-01-22       Impact factor: 7.397

6.  Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  John V Gosselink; Shizu Hayashi; W Mark Elliott; Li Xing; Becky Chan; Luojia Yang; Claire Wright; Don Sin; Peter D Paré; John A Pierce; Richard A Pierce; Alex Patterson; Joel Cooper; James C Hogg
Journal:  Am J Respir Crit Care Med       Date:  2010-01-14       Impact factor: 21.405

7.  Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.

Authors:  Judith Branger; Sylvia Knapp; Sebastiaan Weijer; Jaklien C Leemans; Jennie M Pater; Peter Speelman; Sandrine Florquin; Tom van der Poll
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

8.  Dietary antioxidants and 10-year lung function decline in adults from the ECRHS survey.

Authors:  Vanessa Garcia-Larsen; James F Potts; Ernst Omenaas; Joachim Heinrich; Cecilie Svanes; Judith Garcia-Aymerich; Peter G Burney; Deborah L Jarvis
Journal:  Eur Respir J       Date:  2017-12-21       Impact factor: 16.671

9.  LPS enhances TLR4 expression and IFN‑γ production via the TLR4/IRAK/NF‑κB signaling pathway in rat pulmonary arterial smooth muscle cells.

Authors:  Pengyan Wang; Xuhui Han; Biwen Mo; Guojin Huang; Changming Wang
Journal:  Mol Med Rep       Date:  2017-07-14       Impact factor: 2.952

10.  Phloretin Attenuates Allergic Airway Inflammation and Oxidative Stress in Asthmatic Mice.

Authors:  Wen-Chung Huang; Li-Wen Fang; Chian-Jiun Liou
Journal:  Front Immunol       Date:  2017-02-13       Impact factor: 7.561

View more
  2 in total

1.  Phloretin Protects Bovine Rumen Epithelial Cells from LPS-Induced Injury.

Authors:  Kexin Wang; Qian Lei; Huimin Ma; Maocheng Jiang; Tianyu Yang; Qianbo Ma; Osmond Datsomor; Kang Zhan; Guoqi Zhao
Journal:  Toxins (Basel)       Date:  2022-05-11       Impact factor: 5.075

2.  Antimicrobial and Anti-Inflammatory Activity of Apple Polyphenol Phloretin on Respiratory Pathogens Associated With Chronic Obstructive Pulmonary Disease.

Authors:  Rahel L Birru; Kiflai Bein; Natalya Bondarchuk; Heather Wells; Qiao Lin; Y Peter Di; George D Leikauf
Journal:  Front Cell Infect Microbiol       Date:  2021-11-22       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.